Oracle Acquires Instantis and 4 Hot Stocks Attracting Investor Attention
Oracle (NASDAQ:ORCL) announced its acquisition of Instantis, which develops cloud-based and on premise portfolio project management solutions. The firm’s software could be combined with Oracle’s own Primavera and Fusion Applications, enabling Oracle to provide a very comprehensive offering of cloud-based and on premise PPM solutions. Financial details of the deal were not available.
FXCM Inc (NYSE:FXCM) reports third quarter EPS of $0.17 and revenue of $114.9 million which beat by $0.03 and $8 million respectively.
Catalysts are critical to discovering winning stocks. Check out our newest CHEAT SHEET stock picks now.
Apollo Investment (NASDAQ:AINV) reports third quarter net investment income of $0.22 a share, which is ahead of expectations by $0.01 a share, and up from $0.20 in the previous quarter. EPS is $0.36 a share while net asset value is $8.46 a share.
DUSA Pharmaceuticals (NASDAQ:DUSA) is trading higher by over 37% after the announcement of its acquisition by Indian pharmaceutical company Sun Pharma for $8 a share in cash, which gives the deal a value of approximately $230 million. DUSA is a dermatology company focused on developing and marketing its Levulan (aminolevulinic acid HCl) photodynamic therapy platform.
Boston Scientific (NYSE:BSX) announces a deal to acquire private company Vessix Vascular for $125 million paid in advance, plus milestone based payments of up to $300 million during the period 2013-2017. Vessix Vascular has developed a catheter-based renal denervation system for the treatment of uncontrolled hypertension. According to Mike Mahoney, president and chief executive officer at Boston Scientific, “The acquisition of Vessix Vascular adds a second generation, highly differentiated technology to our hypertension strategy while accelerating our entry into what we expect to be a multi-billion dollar market by 2020.”
Don’t Miss: Is Microsoft Planning to Reward Apple Users?